COPD

GlaxoSmithKline’s triple combo with Innoviva tops Symbicort Turbohaler in COPD
GlaxoSmithKline’s triple combo with Innoviva tops Symbicort Turbohaler in COPD
Mass Device
GSK
Innoviva
Symbicort Turbohaler
COPD
FF/UMEC/VI
AstraZeneca
devices
Flag link:
AZ trumpets positive COPD data to help Symbicort stand up to rivals
AZ trumpets positive COPD data to help Symbicort stand up to rivals
Fierce Pharma
AstraZeneca
COPD
Symbicort
Flag link:
GlaxoSmithKline: New COPD Data Positive For Ex-Advair Franchise
GlaxoSmithKline: New COPD Data Positive For Ex-Advair Franchise
Bidness, ETC
COPD
Advair
GSK
Ellipta
Flag link:
GlaxoSmithKline: Stock To Gain On Triple COPD Trial Success
GlaxoSmithKline: Stock To Gain On Triple COPD Trial Success
Bidness, ETC
GSK
COPD
clinical trials
Flag link:
Boehringer Ingelheim launches gamified support program
Boehringer Ingelheim launches gamified support program
Medical Marketing and Media
Boehringer Ingelheim
Spiriva Respimat
COPD
customer support
Flag link:
GlaxoSmithKline And Innoviva Plan To File A NDA For Triple Combination Therapy
GlaxoSmithKline And Innoviva Plan To File A NDA For Triple Combination Therapy
Yahoo/Benzinga
GSK
Innoviva
fluticasone furoate/umeclidinium/vilanterol
COPD
Flag link:
After setback, GSK's Breo gets boost from real-world data
After setback, GSK's Breo gets boost from real-world data
BioPharma Dive
GSK
Breo
COPD
Flag link:
Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen
Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen
Fierce Biotech
Genentech
asthma
COPD
IL-33
Amgen
Flag link:
Teva goes for laughs in new social media campaign for COPD
Teva goes for laughs in new social media campaign for COPD
Fierce Pharma Marketing
Teva Pharmaceutical
social media
COPD
Flag link:
With a new FDA nod, Novartis enters a crowded COPD field
With a new FDA nod, Novartis enters a crowded COPD field
Fierce Biotech
FDA
Novartis
COPD
QVA149
Flag link:
Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan
Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan
Yahoo
GSK
Theravance
COPD
Japan
Relvar Ellipta
Flag link:
Boehringer finalizes team for crowdsourced COPD R&D initiative
Boehringer finalizes team for crowdsourced COPD R&D initiative
Fierce Biotech
Boehringer Ingelheim
COPD
R&D
crowdsourcing
BioMed X
epigenetics
Flag link:
There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance
There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance
Motley Fool
GSK
Theravance
COPD
Breo Ellipta
Flag link:
GlaxoSmithKline's 'Unexpected Disappointment'
GlaxoSmithKline's 'Unexpected Disappointment'
Yahoo/Benzinga
GSK
COPD
Breo
Flag link:
A COPD outcomes trial could give GSK a $3B-plus Breo boost--or not
A COPD outcomes trial could give GSK a $3B-plus Breo boost--or not
Fierce Pharma Marketing
COPD
GSK
Breo
Flag link:
GSK hopes big clinical trial can breath new life into lung drug
GSK hopes big clinical trial can breath new life into lung drug
Yahoo/Reuters
GSK
clinical trials
Breo
COPD
Flag link:
Boehringer gets respiratory boost with batch of Spiolto nods in EU
Boehringer gets respiratory boost with batch of Spiolto nods in EU
Fierce Pharma
Boehringer Ingelheim
Europe
Spiolto
COPD
Flag link:
Boehringer snags FDA approval for COPD combo drug
Boehringer snags FDA approval for COPD combo drug
Fierce Biotech
FDA
Boehringer Ingelheim
COPD
Stiolto Respimat
Spiriva
Striverdi
Flag link:
Novartis' duo of COPD drugs clears Phase III on the path to an FDA decision
Novartis' duo of COPD drugs clears Phase III on the path to an FDA decision
Fierce Biotech
Novartis
COPD
FDA
NVA237
QVA149
Flag link:
GSK buoyed by early numbers on Anoro, Breo DTC campaigns
GSK buoyed by early numbers on Anoro, Breo DTC campaigns
Fierce Pharma Marketing
GSK
Anoro Ellipta
Breo Ellipta
COPD
Flag link:

Pages